CHRNA5 and hepatocellular carcinoma: From the TCGA database, we observed that a higher expression level of CHRNA5 was correlated with a worse OS in HCC patients receiving sorafenib treatment (Figure 7A), suggesting that CHRNA5 might be associated with sorafenib sensitivity in HCC.